Speaking of this idea of scalability, it might be worth revisiting the Presentation by Anteo Diagnostics CEO at The Australian Biotech Investment Conference 2013 Presentation by Anteo Diagnostics CEO (just click on the blue link).
At around the 2:50 mark the CEO talks about scalability with regards to the two point of care deals.
It can also be found on Twins blog, as part of his initial post on the 19th of November when the price closed at 11 cents, he introduced the video by saying..
"2013 Ausbiotech Microcap Investing Presentation
I will finish this first research post on ADO with the below video of CEO Dr Geoff Cumming presenting. The main turning point for the company and for shareholders is that in the video below Dr Geoff Cumming for the first time gives an idea of the financial potential that may flow in the form of royalties from either of the two point of care companies. Geoff Cumming mentions that either deal will be worth in excess of $10m per year to Anteo Diagnostics. These deals have the potential to see a company valuation in the hundreds of millions. I will cover these in more detail in future posts."
In my mind it is interesting to hear from the CEO's mouth the companies idea of their costs after the anticipated closure of these deals with BBI/Alere and POC 1
questions for martis, page-28
-
- There are more pages in this discussion • 15 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.90M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $23.42K | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1142321 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 339684 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| ADO (ASX) Chart |